Amgen: 11% rise in Q3 adjusted EPS

(CercleFinance.com) - Amgen has announced sales of 6.
7 billion dollars for Q3 2021, up 4% y-o-y.

The US biotech company reported adjusted EBIT of 3.4 billion dollars and adjusted net profit of 2.6 billion dollars, both up 8% relative to Q3 2020.
Adjusted EPS was 4.67 dollars, up 11% y-o-y.

For FY 2021, Amgen now expects total sales of 25.8 billion to 26.2 billion dollars, with adjusted EPS of 16.5 to 17.1 dollars.


Copyright (c) 2021 CercleFinance.com. All rights reserved.